Cargando…

Ocriplasmin use in a selected case with preserved visual acuity

BACKGROUND: Previous studies described cases of Ocriplasmin injections in patients with vitreo-macular traction and reduced central visual acuity. We describe the first case of a patient with 20/20 visual acuity and vitreo-macular traction treated with Ocriplasmin, and, for the first time in literat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossi, Settimio, Orrico, Ada, Melillo, Paolo, Testa, Francesco, Simonelli, Francesca, Della Corte, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625444/ https://www.ncbi.nlm.nih.gov/pubmed/26511080 http://dx.doi.org/10.1186/s12886-015-0141-9

Ejemplares similares

Functional improvement assessed by multifocal electroretinogram after Ocriplasmin treatment for vitreomacular traction
por: Rossi, Settimio, et al.
Publicado: (2016)

Identifying fallers among ophthalmic patients using classification tree methodology
por: Melillo, Paolo, et al.
Publicado: (2017)

Subretinal Fibrosis in Stargardt's Disease with Fundus Flavimaculatus and ABCA4 Gene Mutation
por: Rossi, Settimio, et al.
Publicado: (2012)

En Face Spectral-Domain Optical Coherence Tomography for the Monitoring of Lesion Area Progression in Stargardt Disease
por: Melillo, Paolo, et al.
Publicado: (2016)

Visual function and retinal changes after voretigene neparvovec treatment in children with biallelic RPE65-related inherited retinal dystrophy
por: Testa, Francesco, et al.
Publicado: (2022)

Macular abnormalities in Italian patients with retinitis pigmentosa
por: Testa, Francesco, et al.
Publicado: (2014)

Multimodal Assessment of the Prognostic Role of Ectopic Inner Foveal Layers on Epiretinal Membrane Surgery
por: Gesualdo, Carlo, et al.
Publicado: (2023)

Pupillometric analysis for assessment of gene therapy in Leber Congenital Amaurosis patients
por: Melillo, Paolo, et al.
Publicado: (2012)

Voretigene Neparvovec Gene Therapy in Clinical Practice: Treatment of the First Two Italian Pediatric Patients
por: Testa, Francesco, et al.
Publicado: (2021)

RPE65-associated inherited retinal diseases: consensus recommendations for eligibility to gene therapy
por: Sodi, Andrea, et al.
Publicado: (2021)

Correlation Between Choriocapillaris Density and Retinal Sensitivity in Age-Related Macular Degeneration
por: Di Perna, Luigi, et al.
Publicado: (2021)

The Role of Optical Coherence Tomography in an Atypical Case of Oculocutaneous Albinism: A Case Report
por: Rossi, Settimio, et al.
Publicado: (2012)

Retinoblastoma presenting as pseudohypopyon and preserved visual acuity
por: Blitzer, Andrea L., et al.
Publicado: (2021)

Retinal breaks due to intravitreal ocriplasmin
por: Silva, Ruwan A, et al.
Publicado: (2014)

Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin
por: DaCosta, Joanna, et al.
Publicado: (2014)

Visual functional changes after ocriplasmin injection for vitreomacular traction: A microperimetric analysis
por: Furino, Claudio, et al.
Publicado: (2020)

Ocriplasmin for Vitreoretinal Diseases
por: Tsui, Irena, et al.
Publicado: (2012)

A pilot study for development of a novel tool for clinical decision making to identify fallers among ophthalmic patients
por: Melillo, P, et al.
Publicado: (2015)

Ocriplasmin: who is the best candidate?
por: Prospero Ponce, Claudia M, et al.
Publicado: (2016)

Macular Hole Progression following Ocriplasmin Intravitreal Injection
por: Casswell, Edward, et al.
Publicado: (2014)

Myopic macular hole detachment associated with intravitreal ocriplasmin
por: Goh, Li Yen, et al.
Publicado: (2020)

Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Jackson, Timothy L., et al.
Publicado: (2017)

Italian real-life experience on the use of ocriplasmin
por: Barca, Francesco, et al.
Publicado: (2018)

Ocriplasmin for Treatment of Vitreomacular Traction: An Update
por: Khan, Mohammed Ali, et al.
Publicado: (2016)

Three cases of Charles Bonnet Syndrome in patients with advanced glaucomatous visual field loss but preserved visual acuity
por: Lomo, Trine, et al.
Publicado: (2020)

Recurrent Vitreomacular Traction in a Patient Treated with Ocriplasmin: A Case Report
por: Katsanos, Andreas, et al.
Publicado: (2020)

Serum Iba-1, GLUT5, and TSPO in Patients With Diabetic Retinopathy: New Biomarkers for Early Retinal Neurovascular Alterations? A Pilot Study
por: Trotta, Maria Consiglia, et al.
Publicado: (2022)

A case of Bietti crystalline dystrophy with preserved visual acuity and extinguished electroretinogram: a case report
por: Tabatabaei, Ali, et al.
Publicado: (2009)

Floaters and reduced contrast sensitivity after successful pharmacologic vitreolysis with ocriplasmin
por: Khoshnevis, Matin, et al.
Publicado: (2016)

Multimodal imaging of macular subretinal deposits following intravitreal ocriplasmin injection
por: Chow, Nicholas, et al.
Publicado: (2018)

High Levels of Serum Ubiquitin and Proteasome in a Case of HLA-B27 Uveitis
por: Rossi, Settimio, et al.
Publicado: (2017)

Rhegmatogenous retinal detachment following intravitreal ocriplasmin
por: Madi, Haifa A., et al.
Publicado: (2016)

Bergmeister’s papilla in a young patient with type 1 sialidosis: case report
por: Rossi, Settimio, et al.
Publicado: (2020)

Clinical and genetic features in Italian Bietti crystalline dystrophy patients
por: Rossi, Settimio, et al.
Publicado: (2013)

Resolution of Inflammation in Retinal Disorders: Briefly the State
por: Trotta, Maria Consiglia, et al.
Publicado: (2022)

Lowered intraocular pressure in a glaucoma patient after intravitreal injection of ocriplasmin
por: McClintock, Michael, et al.
Publicado: (2015)

Biofeedback Rehabilitation and Visual Cortex Response in Stargardt's Disease: A Randomized Controlled Trial
por: Melillo, Paolo, et al.
Publicado: (2020)

Incomplete Vitreomacular Traction Release Using Intravitreal Ocriplasmin
por: Chin, Eric K., et al.
Publicado: (2014)

Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion
por: Stefanini, Francisco R, et al.
Publicado: (2014)

OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT Study
por: Steel, David H. W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vcbra5b9abkicb8g1d05kfgmp6